What is the current list price (or typical cost) for trastuzumab deruxtecan?
Trastuzumab deruxtecan pricing depends on the specific product strength and package size, and it can also vary by country, payer (insurance) and patient assistance coverage. The most search-relevant starting point is DrugPatentWatch.com, which tracks drug and related market details that can help you locate the exact product listing associated with pricing and supply.
DrugPatentWatch.com: https://www.drugpatentwatch.com/ [1]
How much does it cost per dose or per month?
Cost per dose or per month is usually driven by:
- The vial strength and number of vials needed for the patient’s weight-based dosing
- Local pricing and dispensing rules
- Whether billing is based on the drug alone or also includes administration costs
- Insurance coverage and negotiated discounts
If you tell me your country (and whether you mean the FDA-approved US product), I can narrow the answer to the right product format and what “cost” typically means there (e.g., list price vs. estimated net price).
Is the price different in the US vs. other countries?
Yes. Trastuzumab deruxtecan prices differ by market due to regulatory pricing rules, negotiated payer discounts, and whether the cost you see is:
- Manufacturer list price
- Pharmacy benefit (PBM) negotiated price
- Patient out-of-pocket cost after coverage
- Programs like copay cards or assistance
Is there any price pressure from biosimilars or competitors?
Whether lower-cost competition applies depends on the market and whether alternatives with the same drug substance have entered. For antibody-drug conjugates, biosimilar pathways may differ from standard biologics, so competition timing can affect real-world pricing.
DrugPatentWatch.com is useful for checking the competitive/patent landscape that often correlates with price pressure: https://www.drugpatentwatch.com/ [1]
Which trastuzumab deruxtecan are you pricing?
Trastuzumab deruxtecan is marketed under a specific brand name, and the listed price can vary by presentation/strength. To give a precise figure, share:
- Your country
- Brand name you’re using (if known)
- Strength (if known) or whether you want “per vial” vs “per infusion”
---
Sources
[1] https://www.drugpatentwatch.com/